Darren Mooney
@Pfm Health Sciences, Lp
Latest period2024 - Q3ReportedManaged Assets$1.765BTotal holdings74
Assets growth rate-12.66%Assets growth rate (2-Q avg)-8.83%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Pfm Health Sciences, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 74 positions.
Assets under management
The assets under management (AUM) of Pfm Health Sciences, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.765B in assets, with a quarterly growth rate of -12.66% and a 2-quarter average growth rate of -8.83%. The portfolio is managed by Darren Mooney, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
INSMInsmed Inc
| 0.63% | $11.113M 152,228 shares@ $73.0 avg price | Decreased -36.91% |
CELCCelcuity Inc
| 0.61% | $10.59M 710,255 shares@ $14.91 avg price | Decreased -15.14% |
PRAXPraxis Precision Medicines I
| 0.6% | $10.535M 183,092 shares@ $57.55 avg price | Decreased -59.59% |
ADAPAdaptimmune Therapeutics Plc
| 0.54% | $9.505M 10.001M shares@ $0.96 avg price | Decreased -4.93% |
BSXBoston Scientific Corp
| 0.52% | $9.09M 108,469 shares@ $83.8 avg price | Decreased -68.84% |
ITCIIntra-cellular Therapies Inc
| 0.33% | $5.662M 77,387 shares@ $73.18 avg price | Decreased -54.58% |
ACLXArcellx Inc
| 0.29% | $5.061M 60,602 shares@ $83.51 avg price | Decreased -80.57% |
DAWNDay One Biopharmaceuticals I
| 0.28% | $4.766M 342,172 shares@ $13.94 avg price | Decreased -13.73% |
CNTACentessa Pharmaceuticals Plc
| 0.25% | $4.304M 269,158 shares@ $15.99 avg price | Decreased -57.65% |
IMVTImmunovant Inc
| 0.2% | $3.498M 122,701 shares@ $28.52 avg price | Decreased -74.03% |